Simpler Grants.gov #HT942526MRPIA

Melanoma Research Program Idea Award for Innovative Melanoma Research

The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), is inviting applications for the Melanoma Research Program (MRP) Idea Award to advance innovative melanoma research. - Government Buyer: - Department of the Army - US Army Medical Research Acquisition Activity (USAMRAA) - Program Details: - Melanoma Research Program (MRP) Idea Award under the Military Medical Research and Development initiative (Assistance Listing 12.420) - Seeks exploratory, high-risk, and potentially high-reward research projects focused on melanoma - Approximately 10 awards anticipated - Total program funding: $5.6 million - Maximum award: $560,000 per project - Maximum period of performance: 2 years per award - Application Requirements: - Pre-application required; only invited applicants may submit full applications - Preliminary data are discouraged - Funding instrument: grant or cooperative agreement - No cost sharing or matching required - Products/Services Requested: - No specific OEMs, vendors, or commercial products involved; this is a research grant opportunity - Service: Melanoma research projects (10 awards) - Unique/Notable Requirements: - Focus on proof-of-principle and preliminary data for future funding - Emphasis on innovation and high-risk/high-reward research - Place of Performance: - US Army Medical Research Acquisition Activity (USAMRAA)

Description

The fiscal year 2026 Melanoma Research Program (MRP) Idea Award supports innovative, exploratory, high-risk/potentially high-reward research focused on melanoma. The program emphasizes novelty and innovation, aiming to establish proof of principle and obtain preliminary data for follow-on funding by the end of the award period. Preliminary data are discouraged, and applicants must submit a pre-application and receive an invitation to submit a full application. Approximately $5.6 million is allocated to fund about 10 awards, each with a total cost cap of $560,000 and a maximum performance period of 2 years.

View original listing